Actively Recruiting
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
Led by Herlev and Gentofte Hospital · Updated on 2022-01-11
500
Participants Needed
1
Research Sites
834 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
CONDITIONS
Official Title
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histological or cytological diagnosis of BTC
- Patients referred for treatment of BTC
- Signed informed consent
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Herlev & Gentofte Hospital
Herlev, Copenhagen, Denmark, 2700
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here